Shattuck Labs STTK
NASDAQ STTK
$6.79 -0.17 (-2.44%)
As of: Sep 4, 2026 · 3:59 PM EDT

Shattuck Labs (STTK) Net Income (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Net Income of -$14.8 million for Q1 2026, down 7.78% year-over-year from -$16.0 million in Q1 2025, and up 87.7% quarter-over-quarter from -$120.1 million in Q4 2025.

Analysis

Shattuck Labs (STTK) Net Income (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Net Income for 8 consecutive years, with -$14.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income fell 7.78% year-over-year to -$14.8 million; the TTM figure through Mar 2026 stood at -$159.1 million (up 7.49% YoY), while the FY2025 annual figure was -$155.5 million, up 9.08% from the prior year.
  • Net Income improved to -$14.8 million in Q1 2026 per STTK's latest filing, from -$120.1 million in the prior quarter.
  • Across five years, Net Income topped out at -$11.1 million in Q3 2025 and bottomed at -$120.1 million in Q4 2025.
  • Historically, Net Income has averaged -$38.3 million across 5 years, with a median of -$26.1 million in 2022.
  • Annual changes were most pronounced in 2023 — Net Income sank 265.61% — and 2025, when it surged 57.77%.
  • Shattuck Labs' Net Income stood at -$26.1 million in 2022, then tumbled by 265.61% to -$95.3 million in 2023, then dropped by 20.9% to -$115.3 million in 2024, then declined by 4.16% to -$120.1 million in 2025, then soared by 87.7% to -$14.8 million in 2026.
  • Business Quant data shows STTK's Net Income at -$14.8 million in Q1 2026, -$120.1 million in Q4 2025, and -$11.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -13.27 Mn
10 Shattuck Labs 885.09 Mn 885.09 Mn - -15.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.13 Mn
Mar 31, 2026 -14.77 Mn
Dec 31, 2025 -13.37 Mn
Sep 30, 2025 -10.72 Mn
Jun 30, 2025 -12.23 Mn
Mar 31, 2025 -13.70 Mn
Dec 31, 2024 -19.64 Mn
Sep 30, 2024 -17.92 Mn
Jun 30, 2024 -22.96 Mn
Mar 31, 2024 -20.04 Mn
Dec 31, 2023 -18.95 Mn
Sep 30, 2023 -28.60 Mn
Jun 30, 2023 -22.75 Mn
Mar 31, 2023 -21.66 Mn
Dec 31, 2022 -26.28 Mn
Sep 30, 2022 -25.23 Mn
Jun 30, 2022 -27.66 Mn
Mar 31, 2022 -24.17 Mn
Dec 31, 2021 7.92 Mn
Sep 30, 2021 -17.33 Mn